Vanguard Group’s Xenetic Biosciences XBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-96,982
| Closed | -$39.4K | – | 4571 |
|
|
2023
Q1 | $39.4K | Sell |
96,982
-61,641
| -39% | -$25K | ﹤0.01% | 4492 |
|
|
2022
Q4 | $45.2K | Sell |
158,623
-457,844
| -74% | -$131K | ﹤0.01% | 4455 |
|
|
2022
Q3 | $331K | Hold |
616,467
| – | – | ﹤0.01% | 4325 |
|
|
2022
Q2 | $494K | Hold |
616,467
| – | – | ﹤0.01% | 4299 |
|
|
2022
Q1 | $629K | Hold |
616,467
| – | – | ﹤0.01% | 4339 |
|
|
2021
Q4 | $795K | Buy |
616,467
+516,490
| +517% | +$666K | ﹤0.01% | 4327 |
|
|
2021
Q3 | $205K | Buy |
99,977
+9,253
| +10% | +$19K | ﹤0.01% | 4486 |
|
|
2021
Q2 | $185K | Hold |
90,724
| – | – | ﹤0.01% | 4375 |
|
|
2021
Q1 | $198K | Buy |
90,724
+51,019
| +128% | +$111K | ﹤0.01% | 4262 |
|
|
2020
Q4 | $81K | Buy |
+39,705
| New | +$81K | ﹤0.01% | 4156 |
|
|
2019
Q2 | – | Sell |
-46,540
| Closed | -$90K | – | 4186 |
|
|
2019
Q1 | $90K | Buy |
46,540
+235
| +0.5% | +$454 | ﹤0.01% | 4021 |
|
|
2018
Q4 | $75K | Buy |
46,305
+10,312
| +29% | +$16.7K | ﹤0.01% | 4033 |
|
|
2018
Q3 | $102K | Buy |
+35,993
| New | +$102K | ﹤0.01% | 4073 |
|